首页 | 本学科首页   官方微博 | 高级检索  
     

依达拉奉治疗急性脑梗死的疗效观察
引用本文:朱东铭,罗成宏,崔玉真. 依达拉奉治疗急性脑梗死的疗效观察[J]. 海南医学, 2006, 17(7): 32-33
作者姓名:朱东铭  罗成宏  崔玉真
作者单位:广东省东莞市石龙人民医院神经内科,广东,东莞,523320;广东省东莞市石龙人民医院神经内科,广东,东莞,523320;广东省东莞市石龙人民医院神经内科,广东,东莞,523320
摘    要:目的观察和验证依达拉奉治疗急性脑梗死的治疗效果.方法161例确诊急性脑梗死患者随机分为两组.治疗组给予依达拉奉30mg加生理盐水250ml静脉滴注,每天2次,共14天,余治疗同对照组.治疗前后定期(入院当日、第7天、第14天、第21天)对患者进行美国国立卫生院卒中患者神经机能缺损评分量表(NIHSS)及日常生活活动能力量表(ADL)评定,并判断临床疗效.结果2周后治疗组较对照组患者NIHSS评分明显降低,P<0.05;日常生活指数行为能力明显提高,P<0.05.治疗组无明显不良反应.结论依达拉奉治疗急性脑梗死安全有效.

关 键 词:急性脑梗死  依达拉奉  自由基清除剂
文章编号:1003-6350(2006)07-032-02

The Clinical effect observation of Edaravone for acute cerebral infarction
ZHU Dong-ming, et al. The Clinical effect observation of Edaravone for acute cerebral infarction[J]. Hainan Medical Journal, 2006, 17(7): 32-33
Authors:ZHU Dong-ming   et al
Affiliation:The Department of Neurology, The Shi Long people Hospital, Dongguan, 523321, China
Abstract:Objective To observate and verify the clinical effect of Edaravone on the patients of acute cerebral infarction. Methods The case-control trail was carried out. 120 inpatients of acute cerebral infarction were randomly divided into two groups- including and control group. Edaravone was infused at a dose of 30mg- twice a day- for 14 days. The therapies of the control group were similar to those of Edaravone group except for Edaravone. The index included National Institutes of Health Stroke(NIHSS) and Barthel exponent of different time (day14- day21). Results NIHSS was significantly decreased in the Edaravone group compared with the control group(P<0.05) and Barthel exponent was increased(P<0.05) after 14 day the patients inpatiented. Conclusions Edaravone is effective and safe for treating acute cerebral infarction.
Keywords:Acute cerebral infarction   Edaravone   Hydroxy-free radical scavenger
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号